Bronchopulmonary dysplasia (BPD) is the most common complication of extreme preterm
birth. Infants who develop BPD manifest aberrant or arrested pulmonary development and …

Approximately 11.1% of all newborns worldwide are born preterm. Improved neonatal
intensive care significantly increased survival rates over the last decades but failed to …

Background Bronchopulmonary dysplasia in premature infants is associated with prolonged
hospitalization, as well as abnormal pulmonary and neurodevelopmental outcome. In …

Background The safety and efficacy of early, low-dose, prolonged therapy with inhaled nitric
oxide in premature newborns with respiratory failure are uncertain. Methods We performed a …

Pathogenesis and treatment of bronchopulmonary dysplasia : Current Opinion in Pediatrics
Pathogenesis and treatment of bronchopulmonary dysplasia : Current Opinion in Pediatrics …

Nitric oxide, an important signaling molecule with multiple regulatory effects throughout the
body, is an important tool for the treatment of full-term and late-preterm infants with persistent …

Hyperoxia disrupts vascular and alveolar growth of the developing lung and contributes to
the development of bronchopulmonary dysplasia (BPD). Endothelial progenitor cells (EPC) …

Supplemental oxygen is often used as a life-saving therapy in the treatment of preterm
infants. However, its protracted use can lead to the development of bronchopulmonary …

Background In animal models, inhaled nitric oxide improved gas exchange and lung
structural development, but its use in premature infants at risk of developing …

First described in 1967 by Northway and colleagues (1), bronchopulmonary dysplasia (BPD)
remains the most prevalent and one of the most serious of the long-term sequelae of preterm …